ACCORD HEALTHCARE, INC.
22 federal recalls on file, showing the 2 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for ACCORD HEALTHCARE, INC. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-08FDA-DrugClass IIAccord levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.
- 2025-10-15FDA-DrugClass IILevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Get notified about new ACCORD HEALTHCARE, INC. recalls
Free weekly digest. We email when a new federal recall affects ACCORD HEALTHCARE, INC. or anything else in your household.
Get the Sunday Brief